MedPath

Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention

Not Applicable
Recruiting
Conditions
Gestational Diabetes
Interventions
Behavioral: Mobile instant messaging-based lifestyle intervention
Behavioral: Text messaging reminders
Behavioral: Brief advice on GDM prevention
Behavioral: Usual care
Registration Number
NCT06061991
Lead Sponsor
The University of Hong Kong
Brief Summary

The goal of this randomised controlled trial is to test the effectiveness of a mobile instant messaging-based lifestyle intervention in pregnant women at risk of gestational diabetes

Detailed Description

Gestational diabetes mellitus (GDM) is one of the most common medical conditions during pregnancy, affecting about 1 in 7 live births worldwide. There remains a lack of proven preventive strategies for GDM that could be readily adopted in clinical practice. Recent studies have suggested that lifestyle intervention delivered via mobile phone could help pregnant women prevent GDM, but more evidence is needed. This study aims to test a mobile instant messaging-based lifestyle intervention for GDM prevention in pregnant women at risk of GDM.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
944
Inclusion Criteria
  1. Ethnic Chinese singleton pregnant woman in <14 weeks of gestation

  2. Aged 18 years or above

  3. Own a mobile phone with an instant messaging app

  4. Not participating in similar trials on diabetes or lifestyle modifications

  5. Have at least one of the following risk factors for GDM:

    • Age ≥35 years at the expected date of delivery
    • Body mass index (BMI) ≥ 25 kg/m2 pre-pregnancy or in the first trimester
    • Family history of diabetes in first-degree relative
    • Previous GDM or delivered a baby with birthweight ≥4 kg
Exclusion Criteria
  • Pre-existing diabetes or other medical conditions that may affect metabolism (e.g., thyroid disorders) or psychiatric disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupBrief advice on GDM preventionMobile instant messaging-based lifestyle intervention
Intervention groupUsual careMobile instant messaging-based lifestyle intervention
Control groupUsual careBrief advice on GDM prevention
Intervention groupMobile instant messaging-based lifestyle interventionMobile instant messaging-based lifestyle intervention
Control groupText messaging remindersBrief advice on GDM prevention
Control groupBrief advice on GDM preventionBrief advice on GDM prevention
Primary Outcome Measures
NameTimeMethod
GDM diagnosisAbout 28th gestational week

GDM diagnosed by a 2-hour 75g oral glucose tolerance test interpreted according to the World Health Organization's 2013 criteria

Secondary Outcome Measures
NameTimeMethod
Hypertensive disorders of pregnancyDuring pregnancy

Including gestational hypertension and preeclampsia

Gestational weight gainFrom baseline to the end of pregnancy (delivery)

Measured in kilograms

BirthweightAt birth

Measured in grams

Neonatal hypoglycaemiaAt birth
Pharmacological therapy for hyperglycaemiaDuring pregnancy

Such as metformin and insulin

Mode of birthAt delivery

Such as normal spontaneous delivery, caesarean section, assisted vaginal delivery

Gestational age at birthAt delivery

Measured in weeks and days

Small for gestational ageAt birth
Large for gestational ageAt birth
Neonatal deathWithin 28 days after birth

Defined as death within 28 days after birth

Preterm birthAt birth

Defined as birth before the 37th gestational week

StillbirthDuring pregnancy

Defined as fetal death after the 20th gestational week

Trial Locations

Locations (4)

Kwong Wah Hospital

🇭🇰

Hong Kong, Hong Kong

United Christian Hospital/ Tseung Kwan O Hospital

🇭🇰

Hong Kong, Hong Kong

Princess Margaret Hospital

🇭🇰

Hong Kong, Hong Kong

Queen Mary Hospital/ Tsan Yuk Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath